(1) This regulation applies to a person if:
(a) the person is required to hold a licence under Part 3 - 3 of the Act; and
(b) the person's turnover of therapeutic goods is not more than $111,065 in a financial year.
(2) The annual charge payable by the person for a licence in
force at any time during the financial year, other than a licence for the
manufacture of human blood and blood components, is 50% of the amount
otherwise payable under subsection 7(5) of the
Therapeutic Goods (Charges) Regulations 2018 for the licence.